Metropolis Healthcare Limited (METROPOLIS.BO)
INR 2132.05
(0.01%)
INR 2132.05
(0.01%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 24.95 INR | -10.61% |
| 2022 | 27.91 INR | -33.34% |
| 2021 | 41.87 INR | 16.4% |
| 2020 | 35.97 INR | 41.84% |
| 2019 | 25.36 INR | 5.4% |
| 2018 | 24.06 INR | 14.57% |
| 2017 | 21.00 INR | 2.54% |
| 2016 | 20.48 INR | 34.3% |
| 2015 | 15.25 INR | 28.26% |
| 2014 | 11.89 INR | 7.8% |
| 2013 | 11.03 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 7.41 INR | 4.22% |
| 2023 Q2 | 6.92 INR | 23.13% |
| 2023 Q1 | 5.62 INR | -13.67% |
| 2023 FY | - INR | -10.61% |
| 2023 Q4 | 7.11 INR | 34.15% |
| 2023 Q3 | 5.30 INR | -23.41% |
| 2022 Q3 | 6.99 INR | -11.29% |
| 2022 Q2 | 7.88 INR | 20.67% |
| 2022 Q1 | 6.53 INR | -16.39% |
| 2022 FY | - INR | -33.34% |
| 2022 Q4 | 6.51 INR | -6.87% |
| 2021 Q1 | 14.65 INR | 22.08% |
| 2021 FY | - INR | 16.4% |
| 2021 Q3 | 8.02 INR | -29.59% |
| 2021 Q4 | 7.81 INR | -2.62% |
| 2021 Q2 | 11.39 INR | -22.25% |
| 2020 Q2 | 11.88 INR | 1984.21% |
| 2020 FY | - INR | 41.84% |
| 2020 Q3 | 11.50 INR | -3.2% |
| 2020 Q4 | 12.00 INR | 4.35% |
| 2020 Q1 | 0.57 INR | -81.55% |
| 2019 Q3 | 8.38 INR | -2.22% |
| 2019 FY | - INR | 5.4% |
| 2019 Q4 | 3.09 INR | -63.13% |
| 2019 Q2 | 8.57 INR | 60.49% |
| 2019 Q1 | 5.34 INR | -22.27% |
| 2018 Q4 | 6.87 INR | 9.74% |
| 2018 Q2 | 6.10 INR | 26.29% |
| 2018 Q3 | 6.26 INR | 2.62% |
| 2018 Q1 | 4.83 INR | 0.0% |
| 2018 FY | - INR | 14.57% |
| 2017 FY | - INR | 2.54% |
| 2016 FY | - INR | 34.3% |
| 2015 FY | - INR | 28.26% |
| 2014 FY | - INR | 7.8% |
| 2013 FY | - INR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 17.90 INR | -39.385% |
| Dr. Lal PathLabs Limited | 43.05 INR | 42.044% |
| Thyrocare Technologies Limited | 13.42 INR | -85.917% |
| Vijaya Diagnostic Centre Limited | 11.62 INR | -114.716% |
| Vimta Labs Limited | 18.51 INR | -34.792% |